Compare CSBR & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSBR | NTIC |
|---|---|---|
| Founded | 1985 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.5M | 82.5M |
| IPO Year | 1986 | N/A |
| Metric | CSBR | NTIC |
|---|---|---|
| Price | $7.57 | $9.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 5.3K | ★ 22.9K |
| Earning Date | 03-10-2026 | 01-08-2026 |
| Dividend Yield | N/A | ★ 0.44% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | $58,424,000.00 | ★ $86,204,962.00 |
| Revenue This Year | $4.84 | $11.40 |
| Revenue Next Year | $11.51 | N/A |
| P/E Ratio | $44.07 | ★ N/A |
| Revenue Growth | ★ 9.06 | N/A |
| 52 Week Low | $5.59 | $6.75 |
| 52 Week High | $11.99 | $12.53 |
| Indicator | CSBR | NTIC |
|---|---|---|
| Relative Strength Index (RSI) | 61.37 | 59.48 |
| Support Level | $6.62 | $8.99 |
| Resistance Level | $7.45 | $9.97 |
| Average True Range (ATR) | 0.31 | 0.50 |
| MACD | 0.05 | -0.02 |
| Stochastic Oscillator | 88.39 | 67.79 |
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.